Loading company…
OraPharma develops dental products for periodontitis treatment and surgical procedures.
OraPharma develops dental products for oral health and dental procedures. Its portfolio includes ARESTIN® microspheres for periodontitis and OSSIX® grafting and membrane products. Johnson & Johnson acquired the company in February 2002 for USD 85 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in